Neurosupportive Role of Vanillin, a Natural Phenolic Compound, on Rotenone Induced Neurotoxicity in SH-SY5Y Neuroblastoma Cells

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Dhanalakshmi, Chinnasamy ^a   Manivasagam, Thamilarasan ^a   Nataraj, Jagatheesan ^a   Justin Thenmozhi, Arokiasamy ^a   Essa, Musthafa Mohamed ^b,c  

^a ANNAMALAI UNIVERSITY   (India)

^b SULTAN QABOOS UNIVERSITY   (Oman)

^c Food and Brain Research Foundation   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; ROTENONE; VANILLIN;

APOPTOSIS; ARTICLE; CELL DEATH; CELL VIABILITY; CELL VIABILITY ASSAY; CONTROLLED STUDY; DOWN REGULATION; FLUORESCENCE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MITOCHONDRIAL MEMBRANE POTENTIAL; MTT ASSAY; NEUROBLASTOMA CELL; NEUROPROTECTION; NEUROTOXICITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; THERAPY EFFECT; UPREGULATION; WESTERN BLOTTING;

EID: 84948823201     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/626028     Document Type: Article

References (67)

1. W. Dauer and S. Przedborski, "Parkinson's disease:mechanisms and models," Neuron, vol. 39, no. 6, pp. 889-909, 2003.
2. R. Betarbet, T. B. Sherer, G. MacKenzie, M. Garcia-Osuna, A. V. Panov, and J. T. Greenamyre, "Chronic systemic pesticide exposure reproduces features of Parkinson's disease," Nature Neuroscience, vol. 3, no. 12, pp. 1301-1306, 2000.
3. M. Alam and W. J. Schmidt, "Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats," Behavioural Brain Research, vol. 136, no. 1, pp. 317-324, 2002.
4. J. T. Greenamyre, R. Betarbet, and T. B. Sherer, "The rotenone model of Parkinson's disease: genes, environment and mitochondria," Parkinsonism and Related Disorders, vol. 9, supplement 2, pp. S59-S64, 2003.
5. T. B. Sherer, J. R. Richardson, C. M. Testa et al., "Mechanism of toxicity of pesticides acting at complex I: relevance to environmental etiologies of Parkinson's disease," Journal of Neurochemistry, vol. 100, no. 6, pp. 1469-1479, 2007.
6. H.-R. Xie, L.-S. Hu, and G.-Y. Li, "SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease," ChineseMedical Journal, vol. 123, no. 8, pp. 1086-1092, 2010.
7. J. M. Gorell, C. C. Johnson, B. A. Rybicki, E. L. Peterson, and R. J. Richardson, "The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living," Neurology, vol. 50, no. 5, pp. 1346-1350, 1998.
8. A. Menegon, P. G. Board, A. C. Blackburn, G. D. Mellick, andD. G. Le Couteur, "Parkinson's disease, pesticides, and glutathione transferase polymorphisms," The Lancet, vol. 352, no. 9137, pp. 1344-1346, 1998.
9. J. B. Martins, M. D. L. Bastos, F. Carvalho, and J. P. Capela, "Differential effects of methyl-4-phenylpyridinium ion, rotenone, and Paraquat on differentiated SH-SY5Y cells," Journal of Toxicology, vol. 2013,Article ID 347312, 10 pages, 2013.
10. M. E. Obrenovich, N. G. Nair, A. Beyaz, G. Aliev, and V. P. Reddy, "The role of polyphenolic antioxidants in health, disease, and aging," Rejuvenation Research, vol. 13, no. 6, pp. 631-643, 2010.
11. B. L. Queen and T. O. Tollefsbol, "Polyphenols and aging," Current Aging Science, vol. 3, no. 1, pp. 34-42, 2010.
12. M. M. Essa, R. K. Vijayan, G. Castellano-Gonzalez, M. A. Memon, N. Braidy, and G. J. Guillemin, "Neuroprotective effect of natural products against Alzheimer's disease," Neurochemical Research, vol. 37, no. 9, pp. 1829-1842, 2012.
13. M. Kavitha, T. Manivasagam, M. M. Essa et al., "Mangiferin antagonizes rotenone: induced apoptosis through attenuating mitochondrial dysfunction and oxidative stress in SK-N-SH neuroblastoma cells," Neurochemical Research, vol. 39, no. 4, pp. 668-676, 2014.
14. S. R. Rao and G. A. Ravishankar, "Vanilla flavour: production by conventional and biotechnological routes," Journal of the Science of Food and Agriculture, vol. 80, no. 3, pp. 289-304, 2000.
15. S. Rakchoy, P. Suppakul, and T. Jinkarn, "Antimicrobial effects of vanillin coated solution for coating paper board intended for packaging bakery products," Asian Journal of Food & Agroindustry, vol. 2, no. 4, pp. 138-147, 2009.
16. H. Imanishi, Y. Sasaki, K. Matsumoto et al., "Suppression of 6-TG-resistant mutations in V79 cells and recessive spot formations in mice by vanillin," Mutation Research Letters, vol. 243, no. 2, pp. 151-158, 1990.
17. K. Ho, L. S. Yazan,N. Ismail, andM. Ismail, "Apoptosis and cell cycle arrest of human colorectal cancer cell line HT-29 induced by vanillin," Cancer Epidemiology, vol. 33, no. 2, pp. 155-160, 2009.
18. S. S. Kumar, K. I. Priyadarsini, and K. B. Sainis, "Inhibition of peroxynitrite-mediated reactions by vanillin," Journal of Agricultural and Food Chemistry, vol. 52, no. 1, pp. 139-145, 2004.
19. S. Gupta and B. Sharma, "Pharmacological benefits of agomelatine and vanillin in experimental model of Huntington's disease," Pharmacology Biochemistry and Behavior, vol. 122, pp. 122-135, 2014.
20. S.-L. Wu, J.-C. Chen, C.-C. Li, H.-Y. Lo, T.-Y. Ho, and C.-Y. Hsiang, "Vanillin improves and prevents trinitrobenzene sulfonic acid-induced colitis in mice," Journal of Pharmacology and Experimental Therapeutics, vol. 330, no. 2, pp. 370-376, 2009.
21. M. Makni, Y. Chtourou, E. M. Garoui, T. Boudawara, and H. Fetoui, "Carbon tetrachloride-induced nephrotoxicity and DNA damage in rats: protective role of vanillin," Human and Experimental Toxicology, vol. 31, no. 8, pp. 844-852, 2012.
22. J. T. Greenamyre, J. R. Cannon, R. Drolet, and P.-G. Mastroberardino, "Lessons from the rotenone model of Parkinson's disease," Trends in Pharmacological Sciences, vol. 31, no. 4, pp. 141-142, 2010.
23. B. V. Manyam and J. R. Sánchez-Ramos, "Traditional and complementary therapies in Parkinson's disease," Advances in Neurology, vol. 80, pp. 565-574, 1999.
24. Q. Li,D. Zhao, and E. Bezard, "TraditionalChinesemedicine for Parkinson's disease: a review of Chinese literature," Behavioural Pharmacology, vol. 17, no. 5-6, pp. 403-410, 2006.
25. T. Mosmann, "Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays," Journal of Immunological Methods, vol. 65, no. 1-2, pp. 55-63, 1983.
26. K. Hafer, K. S. Iwamoto, and R. H. Schiestl, "Refinement of the dichlorofluorescein assay for flow cytometric measurement of reactive oxygen species in irradiated and bystander cell populations," Radiation Research, vol. 169, no. 4, pp. 460-468, 2008.
27. B. Halliwell and M. Whiteman, "Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean" British Journal of Pharmacology, vol. 142, no. 2, pp. 231-255, 2004.
28. L. V. Johnson, M. L. Walsh, and L. B. Chen, "Localization of mitochondria in living cells with rhodamine 123," Proceedings of the National Academy of Sciences of the United States of America, vol. 77, no. 2, pp. 990-994, 1980.
29. R. L. Jayaraj, K. Tamilselvam, T. Manivasagam, and N. Elangovan, "Neuroprotective effect of CNB-001, a novel pyrazole derivative of curcumin on biochemical and apoptotic markers against rotenone-induced SK-N-SH cellular model of parkinson's disease," Journal of Molecular Neuroscience, vol. 51, no. 3, pp. 863-870, 2013.
30. L.-F. Hu,M. Lu, Z.-Y. Wu, P. T.-H. Wong, andJ.-S. Bian, "Hydrogen sulfide inhibits rotenone-induced apoptosis via preservation of mitochondrial function," Molecular Pharmacology, vol. 75, no. 1, pp. 27-34, 2009.
31. H. Bernheimer, W. Birkmayer, O. Hornykiewicz, K. Jellinger, and F. Seitelberger, "Brain dopamine and the syndromes of Parkinson andHuntington. Clinical,morphological and neurochemical correlations," Journal of the Neurological Sciences, vol. 20, no. 4, pp. 415-455, 1973.
32. K. Lirdprapamongkol, H. Sakurai, N. Kawasaki et al., "Vanillin suppresses in vitro invasion and in vivo metastasis of mouse breast cancer cells," European Journal of Pharmaceutical Sciences, vol. 25, no. 1, pp. 57-65, 2005.
33. H. J. Kim, I. K. Hwang, and M. H. Won, "Vanillin, 4-hydroxybenzyl aldehyde and 4-hydroxybenzyl alcohol prevent hippocampal CA1 cell death following global ischemia," Brain Research, vol. 1181, no. 1, pp. 130-141, 2007.
34. A. Bender, K. J. Krishnan, C. M. Morris et al., "High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease," Nature Genetics, vol. 38, no. 5, pp. 515-517, 2006.
35. T. A. Seaton, J. M. Cooper, and A. H. V. Schapira, "Free radical scavengers protect dopaminergic cell lines from apoptosis induced by complex I inhibitors," Brain Research, vol. 777, no. 1-2, pp. 110-118, 1997.
36. D. J. Talpade, J. G. Greene, D. S. Higgins, and J. T. Greenamyre, "In vivo labeling of mitochondrial complex I (NADH: ubiquinone oxidoreductase) in rat brain using [3H]dihydrorotenone," Journal of Neurochemistry, vol. 75, no. 6, pp. 2611-2621, 2000.
37. W. J. H. Koopman, L. G. J. Nijtmans, C. E. J. Dieteren et al., "Mammalian mitochondrial complex I: biogenesis, regulation, and reactive oxygen species generation," Antioxidants and Redox Signaling, vol. 12, no. 12, pp. 1431-1470, 2010.
38. J. F. Turrens, "Mitochondrial formation of reactive oxygen species," The Journal of Physiology, vol. 552, no. 2, pp. 335-344, 2003.
39. J. F. Turrens, "Superoxide production by the mitochondrial respiratory chain," Bioscience Reports, vol. 17, no. 1, pp. 3-8, 1997.
40. B.-S. Choi, H. Kim, H. J. Lee et al., "Celastrol from'ThunderGod Vine' protects SH-SY5Y cells through the preservation of mitochondrial function and inhibition of p38 mapk in a rotenone model of parkinson's disease," Neurochemical Research, vol. 39, no. 1, pp. 84-96, 2014.
41. S.-E. Park, K. Sapkota, J.-H. Choi et al., "Rutin from dendropanax morbifera leveille protects human dopaminergic cells against rotenone induced cell injury through inhibiting JNK and p38 MAPK signaling," Neurochemical Research, vol. 39, no. 4, pp. 707-718, 2014.
42. J.-X. Song, M. Y.-M. Choi, K. C.-K. Wong et al., "Baicalein antagonizes rotenone-induced apoptosis in dopaminergic SHSY5Y cells related to Parkinsonism," Chinese Medicine, vol. 7, article 1, 2012.
43. J. P. Kamat, A. Ghosh, and T. P. A. Devasagayam, "Vanillin as an antioxidant in rat liver mitochondria: inhibition of protein oxidation and lipid peroxidation induced by photosensitization," Molecular and Cellular Biochemistry, vol. 209, no. 1-2, pp. 47-53, 2000.
44. S. Santosh Kumar, K. I. Priyadarsini, and K. B. Sainis, "Free radical scavenging activity of vanillin and o-vanillin using 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical," Redox Report, vol. 7, no. 1, pp. 35-40, 2002.
45. H. Klintworth, K. Newhouse, T. Li, W.-S. Choi, R. Faigle, and Z. Xia, "Activation of c-Jun N-terminal protein kinase is a common mechanism underlying paraquat-and rotenone-induced dopaminergic cell apoptosis," Toxicological Sciences, vol. 97, no. 1, pp. 149-162, 2007.
46. E. Junn andM. M. Mouradian, "Apoptotic signaling in dopamine-induced cell death: the role of oxidative stress, p38mitogenactivated protein kinase, cytochrome c and caspases," Journal of Neurochemistry, vol. 78, no. 2, pp. 374-383, 2001.
47. W. G. Tatton and C. W. Olanow, "Apoptosis in neurodegenerative diseases: the role of mitochondria," Biochimica et Biophysica Acta: Bioenergetics, vol. 1410, no. 2, pp. 195-213, 1999.
48. P. Li, D. Nijhawan, I. Budihardjo et al., "Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade," Cell, vol. 91, no. 4, pp. 479-489, 1997.
49. V. Gogvadze, S. Orrenius, and B. Zhivotovsky, "Multiple pathways of cytochrome c release from mitochondria in apoptosis," Biochimica et Biophysica Acta-Bioenergetics, vol. 1757, no. 5-6, pp. 639-647, 2006.
50. J. C. Reed, "Proapoptotic multidomain Bcl-2/Bax-family proteins: mechanisms, physiological roles, and therapeutic opportunities," Cell Death & Differentiation, vol. 13, no. 8, pp. 1378-1386, 2006.
51. C. X. Wang, J. H. Song,D. K. Song, V. W. Yong,A. Shuaib, andC. Hao, "Cyclin-dependent kinase-5 prevents neuronal apoptosis through ERK-mediated upregulation of Bcl-2," Cell Death and Differentiation, vol. 13, no. 7, pp. 1203-1212, 2006.
52. R. J. Davis, "Signal transduction by the JNK group of MAP kinases," Cell, vol. 103, no. 2, pp. 239-252, 2000.
53. Z. Xia, M. Dickens, J. Raingeaud, R. J. Davis, and M. E. Greenberg, "Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis," Science, vol. 270, no. 5240, pp. 1326-1331, 1995.
54. B.-J. Kim, S.-W. Ryu, and B.-J. Song, "JNK-and p38 kinasemediated phosphorylation of Bax leads to its activation and mitochondrial translocation and to apoptosis of human hepatomaHepG2 cells,"The Journal of Biological Chemistry, vol. 281, no. 30, pp. 21256-21265, 2006.
55. W.-Y. Cheng, C.-Y. Hsiang, D.-T. Bau et al., "Microarray analysis of vanillin-regulated gene expression profile in human hepatocarcinoma cells," Pharmacological Research, vol. 56, no. 6, pp. 474-482, 2007.
56. L. Ernster, G. Dallner, and G. F. Azzone, "Differential effect of rotenone and amytal on mitochondrial electron and energy transfer," The Journal of Biological Chemistry, vol. 238, no. 3, pp. 1124-1131, 1963.
57. J. Fukami, T. Nakatsugawa, and T. Narahashi, "The relation between chemical structure and toxicity in rotenone derivatives," Japanese Journal of Applied Entomology and Zoology, vol. 3, no. 4, pp. 256-265, 1959.
58. J. Fukami and C. Tomizawa, "Effect of rotenone on the-glutamic oxidase system in insect," Botyu-Kagaku, vol. 21, pp. 129-113, 1956.
59. Y. S. Lee, J.-H. Ha, C. S. Yong et al., "Inhibitory effects of constituents of Gastrodia elata Bl. on glutamate-induced apoptosis in IMR-32 human neuroblastoma cells," Archives of Pharmacal Research, vol. 22, no. 4, pp. 404-409, 1999.
60. K. Tamilselvam, J. Nataraj, U. Janakiraman, T. Manivasagam, and M. M. Essa, "Antioxidant and anti-inflammatory potential of hesperidin against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced experimental Parkinson's disease in mice," International Journal of Nutrition, Pharmacology, Neurological Diseases, vol. 3, no. 3, pp. 294-302, 2013.
61. M. M. Essa, S. Subash, C. Dhanalakshmi et al., "Dietary supplementation of walnut partially reverses 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced neurodegeneration in a mouse model of Parkinson's disease," Neurochemical Research, vol. 40, no. 6, pp. 1283-1293, 2015.
62. N. Braidy, S. Selvaraju, M. M. Essa et al., "Neuroprotective effects of a variety of pomegranate juice extracts against MPTPinduced cytotoxicity and oxidative stress in human primary neurons," Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 685909, 12 pages, 2013.
63. V. Singh, N. Guizani, M. M. Essa, F. L. Hakkim, and M. S. Rahman, "Comparative analysis of total phenolics, flavonoid content and antioxidant profile of different date varieties (Phoenix dactylifera L. ) from sultanate of Oman," International Food Research Journal, vol. 19, no. 3, pp. 1063-1070, 2012.
64. K. Tamilselvam, N. Braidy, T. Manivasagam et al., "Neuroprotective effects of hesperidin, a plant flavanone, on rotenoneinduced oxidative stress and apoptosis in a cellular model for Parkinson's disease," OxidativeMedicine and Cellular Longevity, vol. 2013, Article ID 102741, 11 pages, 2013.
65. M. Kavitha, J. Nataraj, M. M. Essa,M. A. Memon, and T. Manivasagam, "Mangiferin attenuatesMPTP induced dopaminergic neurodegeneration and improves motor impairment, redox balance and Bcl-2/Bax expression in experimental Parkinson's disease mice," Chemico-Biological Interactions, vol. 206, no. 2, pp. 239-247, 2013.
66. A. Anandhan, M. M. Essa, and T. Manivasagam, "Therapeutic attenuation of neuroinflammation and apoptosis by black tea theaflavin in chronic MPTP/Probenecid model of parkinson's disease," Neurotoxicity Research, vol. 23, no. 2, pp. 166-173, 2013.
67. S. Lesage and A. Brice, "Parkinson's disease: from monogenic forms to genetic susceptibility factors," Human Molecular Genetics, vol. 18, no. 1, pp. R48-R59, 2009.